Inhibition of Highly Pathogenic Avian H5N1 Influenza Virus Replication by NanoRNA Oligonucleotides

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 2, 2008-06 ,pp. : 101-105

Bentham Science Publishers

Access to resources Recommend Favorite

Influenza A(H1N1)pdm09 virus: therapeutics and challenges

By Saxena Shailendra K   Kotikalapudi Rosaiah   Tiwari Sneham   Muvva Charuvaka  

Future Virology, Vol. 7, Iss. 10, 2012-10 ,pp. : 947-950

Future Medicine

Access to resources Recommend Favorite

Synthesis of New Compounds Combining Adamantanamine and Monoterpene Fragments and their Antiviral Activity Against Influenza Virus A(H1N1)pdm09

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 6, 2013-07 ,pp. : 477-485

Bentham Science Publishers

Access to resources Recommend Favorite

Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics

By Widmer Nicolas  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 741-765

Adis International

Access to resources Recommend Favorite

The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 2, 2008-01 ,pp. : 71-80

Bentham Science Publishers

Access to resources Recommend Favorite